dc.contributor.author |
Yilmaz, S |
|
dc.contributor.author |
Kayaalp, C |
|
dc.contributor.author |
Ara, C |
|
dc.contributor.author |
Yilmaz, M |
|
dc.contributor.author |
Isik, B |
|
dc.contributor.author |
Aydin, C |
|
dc.contributor.author |
Ozgor, D |
|
dc.contributor.author |
Dirican, A |
|
dc.contributor.author |
Barut, B |
|
dc.contributor.author |
Unal, B |
|
dc.contributor.author |
Piskin, T |
|
dc.contributor.author |
Ates, M |
|
dc.contributor.author |
Kutlu, R |
|
dc.contributor.author |
Toprak, HI |
|
dc.contributor.author |
Bayindir, Y |
|
dc.contributor.author |
Kirimlioglu, H |
|
dc.contributor.author |
Aladag, M |
|
dc.contributor.author |
Harputluoglu, M |
|
dc.contributor.author |
Selimoglu, A |
|
dc.contributor.author |
Karabiber, H |
|
dc.contributor.author |
Yalcin, K |
|
dc.contributor.author |
Kirimlioglu, V |
|
dc.date.accessioned |
2022-10-13T12:36:31Z |
|
dc.date.available |
2022-10-13T12:36:31Z |
|
dc.date.issued |
2013 |
|
dc.identifier.uri |
http://hdl.handle.net/11616/80391 |
|
dc.description.abstract |
Background/Aims: Living donor liver transplantations (LDLT) is a definitive treatment for patients with end-stage liver disease (ESLD), especially in the countries with donation problem. Between April 2007 and April 2010, we performed LDLT in 289 patients. Fifteen of the cases required re-transplantations. This study evaluates these 304 consecutive LDLTs donor and recipient outcomes. Methodology: Complication rates and survival data of the recipients and donors of 304 LDLT cases were analyzed. Results: All donors are alive and well. Overall complication rate was 27%. Early postoperative recipient complication rate was 51%. Most frequent complication was infection. In the long-term there were 57 biliary stricture and 5 chronic bile fistula cases. Chronic and acute rejection attacks developed in 7 and 103 patients, respectively. Hepatic artery thrombosis rate was 8%. One, two and three year survival rates were 82%, 79% and 75%, respectively. Recipient mortality was 25%, mostly due to vascular complications, septic complications, liver dysfunction and chronic rejection. Conclusions: More than 150 liver tranplantations per year in a single center is a challenge in Turkey, where there is a shortage of deceased donor grafts. LDLT is a safe procedure for donors and effective for ESLD. Improvement in surgical technique would provide better outcomes. |
|
dc.description.abstract |
C1 [Yilmaz, Sezai; Kayaalp, Cuneyt; Ara, Cengiz; Yilmaz, Mehmet; Isik, Burak; Aydin, Cemalettin; Ozgor, Dincer; Dirican, Abuzer; Barut, Bora; Unal, Bulent; Piskin, Turgut; Ates, Mustafa; Kirimlioglu, Vedat] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Dept Gen Surg, Malatya, Turkey. |
|
dc.description.abstract |
[Yilmaz, Sezai; Kayaalp, Cuneyt; Ara, Cengiz; Yilmaz, Mehmet; Isik, Burak; Aydin, Cemalettin; Ozgor, Dincer; Dirican, Abuzer; Barut, Bora; Unal, Bulent; Piskin, Turgut; Ates, Mustafa; Kirimlioglu, Vedat] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Liver Transplantat Unit, Malatya, Turkey. |
|
dc.description.abstract |
[Kutlu, Ramazan] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Dept Radiol, Malatya, Turkey. |
|
dc.description.abstract |
[Toprak, Huseyin Ilksen] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Dept Anesthesiol, Malatya, Turkey. |
|
dc.description.abstract |
[Bayindir, Yasar] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Dept Infect Dis, Malatya, Turkey. |
|
dc.description.abstract |
[Kirimlioglu, Hale] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Dept Pathol, Malatya, Turkey. |
|
dc.description.abstract |
[Aladag, Murat; Harputluoglu, Murat; Yalcin, Kendal] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Dept Transplantat Hepatol, Malatya, Turkey. |
|
dc.description.abstract |
[Selimoglu, Ayse; Karabiber, Hamza] Inonu Univ, Sch Med, Turgut Ozal Med Ctr, Dept Pediat Transplantat Hepatol, Malatya, Turkey. |
|
dc.source |
HEPATO-GASTROENTEROLOGY |
|
dc.title |
Single-Center Analysis of the First 304 Living-Donor Liver |
|
dc.title |
Transplantations in 3 Years |
|